Discuss This Drug

TRASTUZUMAB

CHEBI:CHEBI_752070

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
Trastuzumab Emtansine
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
product_type
BULK INGREDIENT
listing_expiration_date
20241231
marketing_start_date
20191103
route
INTRAVENOUS
marketing_category
BULK INGREDIENT
labeler_name
Cephalon, Inc.
brand_name
Herceptin
brand_name_base
Herceptin
application_number
BLA103792
product_ndc
63552-037
spl_id
a13f265f-1f3a-4967-8637-e6e14cba822f
package_ndc
63552-037-00
rxcui
1922512
active_ingredient_strength
420 mg/17.6mL
package_marketing_start_date
19-JUN-19
nui
N0000020008
pharm_class_epc
HER2/neu Receptor Antagonist [EPC]
pharm_class
HER2/Neu/cerbB2 Antagonists [MoA]
pharm_class_moa
HER2/Neu/cerbB2 Antagonists [MoA]
manufacturer_name
Cephalon, Inc.
unii
P188ANX8CK
active_ingredient_name
TRASTUZUMAB EMTANSINE
package_description
143 VIAL in 1 TRAY (63552-037-00) / 15 mL in 1 VIAL
spl_set_id
492dbdb2-077e-4064-bff3-372d6af0a7a2
upc
0378206148018
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class